Amy DiCamillo

Corporate Officer/Principal at Melior Discovery, Inc.

Commercial Services

Consumer Services

Amy DiCamillo active positions

Companies	Position	Start	End
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Corporate Officer/Principal	-	-
	Chief Tech/Sci/R&D Officer	-	-

West Chester University of Pennsylvania

Graduate Degree

International

United States

Operational

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Graduate Degree	1

Sectoral

Commercial Services	2
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	1
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Commercial Services

Private companies

Commercial Services